Omicron-Specific Pfizer Vaccine's Clinical Trials Begin To Test Efficiency and Safety

The Omicron-specific Pfizer vaccine is about to start its clinical trials. The drugmaker aims to enroll more than 1,400 participants.

Related Keywords

United Kingdom ,White House ,District Of Columbia ,United States ,Biontech Covid ,Anthony Fauci ,Griffin Davis ,Justin Tallis ,Pfizer ,Drug Administration ,Us Army ,Tech Times ,Omicron Specific Pfizer ,Specific Pfizer Vaccine ,Clinical Trials Begin To Test Efficiency ,Getty Images ,Kids Still Not ,White House Chief Medical Advisor ,Completes Phase ,How Effective ,Against Coronavirus ,Omicron ,Pfizer Vaccine ,Odified Pfizer Vaccine ,Fizer Vaccine Clinical Trials ,